Skip to main content

Quest Diagnostics Incorporated Under Investor Investigation Over Possible Breaches Of Fiduciary Duties

  • If you are a current long term investor in shares of Quest Diagnostics Incorporated (NYSE: DGX), and/or if you have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

After Quest Diagnostics agreed to pay $241 million to settle a lawsuit that alleged the Company overcharged California's Medicaid program an investigation on behalf of on behalf of investors in shares of Quest Diagnostics Incorporated (NYSE:DGX) over possible breaches of fiduciary duties by certain officers and directors at Quest Diagnostics Inc. was announced. The investigation by a ...



You must register (for free) or login to view the entire investigation.